![]() |
Volumn 5, Issue 4, 2007, Pages 521-
|
Epstein-Barr Virus-Associated Lymphoma Developed Shortly After Immunosuppressive Treatment for Ulcerative Colitis
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AZATHIOPRINE;
IMMUNOSUPPRESSIVE AGENT;
PREDNISOLONE;
B CELL LYMPHOMA;
CASE REPORT;
ENTERITIS;
EPSTEIN BARR VIRUS;
HUMAN;
IMMUNE DEFICIENCY;
IMMUNOSUPPRESSIVE TREATMENT;
LETTER;
LYMPHOCYTE PROLIFERATION;
LYMPHOMA;
LYMPHOPROLIFERATIVE DISEASE;
RISK FACTOR;
SERODIAGNOSIS;
TRANSPLANTATION;
TREATMENT DURATION;
ULCERATIVE COLITIS;
VIRUS INFECTION;
COLITIS, ULCERATIVE;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
EPSTEIN-BARR VIRUS INFECTIONS;
HUMANS;
IMMUNOCOMPROMISED HOST;
IMMUNOSUPPRESSIVE AGENTS;
LYMPHOMA, B-CELL;
PROGNOSIS;
RISK ASSESSMENT;
SEVERITY OF ILLNESS INDEX;
|
EID: 34147159686
PISSN: 15423565
EISSN: None
Source Type: Journal
DOI: 10.1016/j.cgh.2007.02.003 Document Type: Letter |
Times cited : (5)
|
References (3)
|